Systemic medication usage in glaucoma patients
| Autor: | Oscar Kasner, Deborah Anne Samek, David Gerardo Camoriano, Ali K. Mohammed, Tenley N. Bower, Paul Kasner, Ahmed Q. Mohammed |
|---|---|
| Rok vydání: | 2018 |
| Předmět: |
Male
medicine.medical_specialty Visual acuity genetic structures medicine.drug_class Cross-sectional study Visual Acuity Pharmacist Glaucoma 03 medical and health sciences 0302 clinical medicine Internal medicine Anticholinergic Humans Medicine Prospective Studies 030212 general & internal medicine Prospective cohort study Antihypertensive Agents Intraocular Pressure Aged Univariate analysis business.industry General Medicine medicine.disease eye diseases Ophthalmology Cross-Sectional Studies 030221 ophthalmology & optometry Female Observational study Visual Fields medicine.symptom business |
| Zdroj: | Canadian Journal of Ophthalmology. 53:242-245 |
| ISSN: | 0008-4182 |
| Popis: | Objective To study the prevalence of the systemic use of some common classes of medications by glaucoma patients and their relationship to the prevalence and severity of chronic open-angle glaucoma (COAG) and primary-angle closure glaucoma (PACG). Design Observational prospective single-centre cross-sectional study. Methods Glaucoma patients or their pharmacist provided an updated list of all systemic medications that they presently use. The relationship between glaucoma type and severity and medication use for diseases other than glaucoma was assessed by univariate statistics. Results We studied 514 glaucoma patients. They use a mean of 4.9 oral medications prescribed by a mean of 2.1 doctors. Antihypertensives, medications with anticholinergic properties, steroids, anticoagulants, and thyroid hormones were the most frequently prescribed groups of medications, used by 251 (49%), 178 (35%), 100 (19%), 218 (42%), and 108 (21%) patients, respectively. Steroid usage was associated with advanced visual field loss in COAG patients. Antihypertensives and medications with anticholinergic properties were not associated with severity of COAG and PACG, respectively, and these 3 groups were not associated with an increased prevalence of diagnosis of COAG or PACG. Conclusion Glaucoma patients take many systemic medications in addition to their topical glaucoma treatment. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect